LONDON, GB / ACCESS Newswire / March 28, 2025 / Black Book Market Research, a leading independent and unbiased technology ...
SALT LAKE CITY, UTAH / ACCESS Newswire / March 28, 2025 / PointClickCare, a leading healthcare technology platform enabling meaningful collaboration across the care continuum, and VistaRx, a ...
Find out the change in Physiotherapy DUBAI, UAE / ACCESS Newswire / March 28, 2025 / Since the immerge of healthcare innovation and technology, there has been significant change that's complementing ...
Eli Lilly and Company (LLY) has expanded its LillyDirect digital healthcare platform to offer connections to independent ...
The Global Nutraceuticals Market valued at $416 billion (2021), is expected to witness a growth rate of 8-9% in the next five years.Need for dietary and food supplements stems from a sedentary ...
Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...
Advancing sustainability in laboratory operations~ Driving environmental conservation through responsibility, collaboration, and innovation ~ Broughton, a leading analytical testing and consultancy ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., a clinical-stage company ...
Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...
Curium Pharma (“Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products Co. (Monrol), a leading nuclear medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results